Peter Weeke

Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death

Connie R. Bezzina, Julien Barc, Yuka Mizusawa et al. · Nature Genetics · 2013 · 540 citations · Full text

Cardiomyopathy, Genetic Disorder, Genetics +9

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

Mikhail Kosiborod, John Deanfield, Richard Pratley et al. · The Lancet · 2024 · 216 citations

Heart Failure, Cardiovascular Disease, Cardiovascular Pharmacology +9

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

John Deanfield, Subodh Verma, Benjamin M. Scirica et al. · The Lancet · 2024 · 177 citations · Full text

Role of common and rare variants in <i>SCN10A</i>: results from the Brugada syndrome QRS locus gene discovery collaborative study

Elijah R. Behr, Eleonora Savio‐Galimberti, Julien Barc et al. · Cardiovascular Research · 2015 · 106 citations · Full text

SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation

Eleonora Savio‐Galimberti, Peter Weeke, Raafia Muhammad et al. · Cardiovascular Research · 2014 · 78 citations · Full text